Radiofrequency Ablation Devices Market by Product, End User, Application and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Radiofrequency Ablation Devices Market size was valued at USD 5.17 Billion in 2025 and the total Radiofrequency Ablation Devices revenue is expected to grow at a CAGR of 11.8% from 2025 to 2034, reaching nearly USD 14.12 Billion.
Radiofrequency Ablation Devices Market Overview:
Radiofrequency ablation (RFA) is a medical procedure, which uses thermal energy to accomplish targeted tissue destruction. This is done using an electrosurgical generator connected to bipolar electrode arrays to deliver thermal energy to tissue. RFA is generally conducted in the outpatient setting, using either local anaesthetics or conscious sedation anaesthesia.
Radiofrequency Ablation Devices Market Growth Share Analysis
To Know About The Research Methodology :- Request Free Sample Report
Radiofrequency Ablation Devices Market Dynamics:
Emerging applications of Radiofrequency Ablation technology primarily drive market growth.
RFA technology is used to treat a wide range of medical conditions. It is used in the treatment of tumour spot, to treat patients suffering from the adrenal gland, breast, bone, kidney, liver, lung, pancreatic, and thyroid cancer.
This technology has also gained a lot of attention in the field of dermatology to treat skin lesions, freckles, acne and skin tags. All these advantages of the RFA technology help in boosting the market growth. Growing healthcare expenditure and preference for minimally invasive surgeries has become a major factor in driving the market growth.
The report has profiled Seventeen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Radiofrequency Ablation Devices Market Segment Analysis:
The Global Radiofrequency Ablation Devices Market is segmented on the basis of Product, Application and End-users.
Based on Product, the disposable segment is expected to register the highest CAGR of 10.8% during the forecast period.Being a relatively low toxic and reduced risk of complications is driving the growth of the disposable radiofrequency ablation devices market. Product launches are also expected to drive RF ablation devices market growth over the forecast period. In, Medtronic launched the OsteoCool RF Ablation system in Canada for bone metastasis. This is the only radiofrequency ablation system with dual-probe capabilities that provides the customized, flexible, and predictable treatment.
Radiofrequency Ablation Devices Market Regional Insights:
North America is expected to hold a significant market share during forecast years.
Based on the geographical analysis, North America is anticipated to dominate the market growth owing to the high prevalence of cancer, increasing technological advancements, high purchasing power, and government support for quality healthcare. According to the American Cancer Society, in , around 1,762,450 people were diagnosed with cancer in the US.
The Asia Pacific is expected to grow at a faster pace during forecast years.
APAC is expected to witness lucrative growth due to the presence of factors such as increasing awareness for cardiac disease, growing healthcare industries, and the development of various treatment methods for gynaecology and cosmetology that drive the market in this region. Also, Ongoing technological advances and R&D activities in the region will create potential growth opportunities.
The report also helps in understanding the Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.
Radiofrequency Ablation Devices Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 25 June 2026 | Johnson & Johnson | Johnson & Johnson MedTech launched its Dual Energy THERMOCOOL SMARTTOUCH SF Platform commercially in Europe, combining radiofrequency (RF) and pulsed field energy in a single catheter system. | The launch enhances procedural flexibility and treatment personalization for electrophysiologists treating cardiac arrhythmias by allowing seamless energy switching within familiar RF workflows. |
| 15 April 2026 | Avanos Medical, Inc. | Avanos Medical entered into a definitive agreement to be acquired by American Industrial Partners in an all-cash transaction valued at approximately USD 1.272 billion. | The acquisition expands dedicated resources and private capital backing for Avanos's non-opioid chronic pain portfolio, including its flagship COOLIEF cooled radiofrequency ablation therapy. |
| 12 March 2026 | Medtronic plc | Medtronic partnered with Merit Medical Systems to distribute the FDA-cleared ViaVerte system for targeted radiofrequency ablation. | The strategic distribution collaboration expands market access to minimally invasive basivertebral nerve ablation options for patients suffering from chronic low back pain. |
| 18 August 2025 | Boston Scientific Corporation | Boston Scientific received U.S. FDA 510(k) clearance for its GX1 Radiofrequency Generator System designed for neurological lesion creation. | The clearance accelerates U.S. commercial adoption of next-generation RFA capital equipment used in conjunction with specialized RFA electrodes and cannulae for chronic pain management. |
| 10 January 2025 | Johnson & Johnson | Johnson & Johnson MedTech secured European CE Mark approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Catheter powered by the TRUPULSE Generator. | The regulatory milestone established European market approval for integrated radiofrequency and pulsed field energy toggling within electro-anatomical mapping systems. |
Radiofrequency Ablation Devices Market Scope: Inquire before buying
| Radiofrequency Ablation Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 5.17 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 11.8% | Market Size in 2034: | USD 14.12 Bn. |
| Segments Covered: | by Product | Disposable Capital Reusable Equipment |
|
| by End User | Hospital Clinics Ambulatory |
||
| by Application | Sutgical Oncology Cardiology Gynecology Cosmetology Pain Management |
||
Radiofrequency Ablation Devices Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and the Rest of APAC)
South America (Brazil, Argentina Rest of South America)
Middle East & Africa (South Africa, GCC, Egypt, Nigeria and the Rest of ME&A)
Radiofrequency Ablation Devices Market, Key Players
1. Boston Scientific Corporation
2. Medtronic
3. Stryker
4. Cosman Medical, Inc.
5. St. Jude Medical
6. Smith & Nephew
7. Johnson & Johnson (J&J) Services, LLC
8. AngioDynamics
9. AvanosMedical Inc.
10. Abbott
11. Bard (BD)
12. Hologic
13. Articure
14. Merit medical
15. Accuray, Inc.
16. Kimberly-Clark Corporation
17. Biosense Webster, Inc.
Frequently Asked Questions:
1. Which region has the largest share in Global Radiofrequency Ablation Devices Market?
Ans: North America region holds the highest share in 2025.
2. What is the growth rate of Global Radiofrequency Ablation Devices Market?
Ans: The Global Market is growing at a CAGR of 11.8% during forecasting period 2026-2034.
3. What is scope of the Global Radiofrequency Ablation Devices Market report?
Ans: Global Radiofrequency Ablation Devices Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. What was the Global Radiofrequency Ablation Devices Market size in 2025?
Ans: The Global Radiofrequency Ablation Devices Market size was USD 5.17 Billion in 2025.